Perioperative chemotherapy treatment did not improve overall survival for patients with resectable pancreatic cancer, according to a recent Northwestern Medicine clinical trial.
Month: February 2021
A model forged at Northwestern, academic affiliations with Veteran’s hospitals changed American medicine — providing care for veterans, training for future physicians and advancing scientific discovery.
Blocking the arginine methylation pathway, which helps brain tumor cells proliferate by promoting cell division, could improve cancer therapies, according to a recent study.
Working with large, multicenter teams, Northwestern clinician-scientists have examined treatments for blood clotting in critically ill patients with COVID-19, and explored therapies that could reduce disease progression and hospitalization.
Inhibiting an inflammatory pathway reduced heart attack-induced damage in experimental models, according to a recent Northwestern Medicine study.
Alyssa Martinez, a second-year student in the Doctor of Physical Therapy (DPT) program, recently put her newly acquired medical skills to use to help save a man’s life.
For the first time, Northwestern Medicine scientists have characterized how a genetic mutation associated with pediatric epilepsy affects neuron activity.
Northwestern Medicine investigators have discovered that inhibiting a specific autophagy protein found in dopaminergic neurons may prevent reward-related behaviors induced by cocaine misuse.
Northwestern Medicine investigators have identified a protein kinase called DYRK1A and its downstream substrates as potential therapeutic targets for treating pediatric patients with B-cell acute lymphoblastic leukemia.
A new antibody drug demonstrated similar efficacy to currently available therapies to treat advanced ERBB2-positive breast cancer, according to a recent clinical trial.